Thursday | IBM
UCB and IBM Collaborate to Personalize Care for Epilepsy Patients
The milestone marks the critical first step in the path towards eventually harnessing the transformative power of cognitive computing capabilities, such as IBM Watson, for epilepsy care.
FDA Issues Warning about More Depakote Birth Defect Risk
After a new study linked Depakote and other valproate medications taken during pregnancy to an increased risk of autism and autism spectrum disorders, the FDA has decided to put its strongest warning for pregnancy associated complications on the drug, designating it pregnancy class X for migraine prevention, which means that the drug's dangers ... (more)
Nearly 300 bike helmets donated to elementary students
The Epilepsy Foundation of East Tennessee and the Lawyers of Brown and Roberto donated nearly 300 bike helmets to elementary students around Knoxville.
Washington SHB 1541 Signed Into Law
Wednesday signed into law Substitute House Bill 1541 adding nasal spray medications to a list of medications able to be administered to school age children in .
Brain Implant: Microchip Could Restore Memory
Brain implants in the form of microchips may be able to restore memory in the not-so-distant future, researchers say.
New Market Report: Banzel / Inovelon (Epilepsy) - Forecast and Market Analysis to 2022
GlobalData has released its new PharmaPoint Drug Evaluation report, "Banzel / Inovelon - Forecast and Market Analysis to 2022". Epilepsy is a brain disorder characterized by spontaneously occurring and recurrent seizures.
Injecting new neurons helps tone down epileptic seizures
When most people think of the nervous system, they think of it as a hub of activity.
Getting enough exercise; migraine drug warning: Healthy Living
The U.S. Centers for Disease Control and Prevention is inclined to think not. The agency reports that only one in five U.S. adults gets the recommended amount of aerobic and muscle strengthening exercise.
Brain implants: Restoring memory with a microchip
U.S. researchers are hopeful that human trials on a revolutionary memory implant could get underway in the next two years.
FDA: Don't take valproate for migraines while pregnant
The FDA has alerted healthcare providers and patients that medications including and related to valproate sodium can cause decreased IQ scores in children whose mothers took the medication during pregnancy.
Monmouth Medical Center Epilepsy Program Receives National Designation
The Epilepsy Monitoring Program at Monmouth Medical Center, a Barnabas Health facility, recently received the distinction of a Level 3 designation from the National Association of Epilepsy Centers.
FDA warns pregnant women against migraine drugs
Some migraine medications can cause pregnant mothers to give birth to children with lower intelligence, the federal government is warning.
Coral Reef studeCoral Reef student advocates for epilepsy programs in ...
Coral Reef Senior High School sophomore Alexandra Markovich represented the Epilepsy Foundation of Florida and served as Florida's ambassador during the annual Kids Speak Up! conference, Apr.
Alexza Pharmaceuticals, Inc. to Present at Antiepileptic Drug and...
Alexza Pharmaceuticals, Inc. to Present at Antiepileptic Drug and Device Trials XII Conference Highlighting Advances in the Treatment of Epilepsy /PRNewswire/ -- Alexza Pharmaceuticals, Inc.
Myoclonus and epilepsy in childhood: a review of treatment with...
Based on small numbers of patients, it is possible to make the following suggestions rather than categorical statements.
Media advisory: Brain cell injections may quiet epileptic seizures
More than two million people in the United States suffer from epilepsies, a group of neurological disorders caused by abnormal nerve cell firing in the brain which often produce debilitating seizures.
Supernus Secures Financing For CNS Pipeline Development
Supernus Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases.
Epilepsy and antiepileptic drug therapy in juvenile neuronal ceroid lipofuscinosis.
To survey the characteristics of epilepsy in patients with juvenile neuronal ceroid lipofuscinosis and determine the antiepileptic drug treatment most suitable for these patients.
Brain implant is able to predict seizures in epileptic patients
The device monitors the brain's electrical activity and alerts patients when they are most likely to experience an epileptic fit.
Implanted device predicts epilepsy seizures in humans
For the first time, a small device implanted in the brain has accurately predicted the onset of seizures in some adults who have epilepsy that doesn't respond to drugs, according to a small proof-of-concept study published Online First in The Lancet Neurology .